-
1
-
-
0036079613
-
Review of raloxifene and its clinical applications in osteoporosis
-
Maricic M, Gluck O. Review of raloxifene and its clinical applications in osteoporosis. Expert Opin Pharmacother 2002;3:767-75
-
(2002)
Expert Opin Pharmacother
, vol.3
, pp. 767-775
-
-
Maricic, M.1
Gluck, O.2
-
2
-
-
0033581212
-
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
-
Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. J Am Med Assoc 1999;282:637-45
-
(1999)
J Am Med Assoc
, vol.282
, pp. 637-645
-
-
Ettinger, B.1
Black, D.M.2
Mitlak, B.H.3
-
3
-
-
18544381541
-
Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial
-
Delmas PD, Ensrud KE, Adachi JD, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab 2002;87:3609-17
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3609-3617
-
-
Delmas, P.D.1
Ensrud, K.E.2
Adachi, J.D.3
-
4
-
-
0037182042
-
Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis
-
Maricic M, Adachi JD, Sarkar S, et al. Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med 2002;162:1140-3
-
(2002)
Arch Intern Med
, vol.162
, pp. 1140-1143
-
-
Maricic, M.1
Adachi, J.D.2
Sarkar, S.3
-
5
-
-
0027364981
-
The epidemiology of vertebral fractures [European Vertebral Osteoporosis Study Group]
-
European Vertebral Osteoporosis Study Group
-
Cooper C, O'Neill T, Silman A. The epidemiology of vertebral fractures [European Vertebral Osteoporosis Study Group]. Bone 1993;14(Suppl 1)S89-S97
-
(1993)
Bone
, vol.14
, Issue.SUPPL. 1
-
-
Cooper, C.1
O'Neill, T.2
Silman, A.3
-
6
-
-
0035900949
-
Risk of new vertebral fracture in the year following a fracture
-
Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. J Am Med Assoc 2001;285:320-3
-
(2001)
J Am Med Assoc
, vol.285
, pp. 320-323
-
-
Lindsay, R.1
Silverman, S.L.2
Cooper, C.3
-
7
-
-
0032524460
-
The association of radiographically detected vertebral fractures with back pain and function: A prospective study
-
Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 1998;128:793-800
-
(1998)
Ann Intern Med
, vol.128
, pp. 793-800
-
-
Nevitt, M.C.1
Ettinger, B.2
Black, D.M.3
-
8
-
-
0033553866
-
Vertebral fractures and mortality in older women: A prospective study
-
Study of Osteoporotic Fractures Research Group
-
Kado DM, Browner WS, Palermo L, et al. Vertebral fractures and mortality in older women: a prospective study [Study of Osteoporotic Fractures Research Group]. Arch Intern Med 1999;159:1215-20
-
(1999)
Arch Intern Med
, vol.159
, pp. 1215-1220
-
-
Kado, D.M.1
Browner, W.S.2
Palermo, L.3
-
9
-
-
7944237873
-
Safety and adverse effects associated with raloxifene: Multiple outcomes of raloxifene evaluation
-
Grady D, Ettinger B, Moscarelli E, et al., for the Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. Safety and adverse effects associated with raloxifene: Multiple Outcomes of Raloxifene Evaluation. Obstet Gynecol 2004;104:837-44
-
(2004)
Obstet Gynecol
, vol.104
, pp. 837-844
-
-
Grady, D.1
Ettinger, B.2
Moscarelli, E.3
-
11
-
-
0038219496
-
-
Cambridge (MA)
-
Anon. StatXact5 user manual. Cambridge (MA):2001;515-7
-
(2001)
StatXact5 User Manual
, pp. 515-517
-
-
-
12
-
-
0031765564
-
Updated data on proximal femur bone mineral levels of US adults
-
Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998;8:468-89
-
(1998)
Osteoporos Int
, vol.8
, pp. 468-489
-
-
Looker, A.C.1
Wahner, H.W.2
Dunn, W.L.3
-
13
-
-
0141750678
-
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: Results from the MORE trial
-
Delmas PD, Genant HK, Crans G, et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 2003;33:522-32
-
(2003)
Bone
, vol.33
, pp. 522-532
-
-
Delmas, P.D.1
Genant, H.K.2
Crans, G.3
-
14
-
-
0036851816
-
Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: Results from the MORE study. Multiple Outcomes of Raloxifene Evaluation
-
Siris E, Adachi JD, Lu Y, et al. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation. Osteoporos Int 2002;13:907-13
-
(2002)
Osteoporos Int
, vol.13
, pp. 907-913
-
-
Siris, E.1
Adachi, J.D.2
Lu, Y.3
-
15
-
-
0033552255
-
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial
-
Vertebral Efficacy With Risedronate Therapy (VERT) Study Group
-
Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial [Vertebral Efficacy With Risedronate Therapy (VERT) Study Group]. J Am Med Assoc 1999;282:1344-52
-
(1999)
J Am Med Assoc
, vol.282
, pp. 1344-1352
-
-
Harris, S.T.1
Watts, N.B.2
Genant, H.K.3
-
16
-
-
12944291524
-
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
-
Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000;11:83-91
-
(2000)
Osteoporos Int
, vol.11
, pp. 83-91
-
-
Reginster, J.1
Minne, H.W.2
Sorensen, O.H.3
-
17
-
-
11144354206
-
Efficacy of risedronate on clinical vertebral fractures within six months
-
Roux C, Seeman E, Eastell R, et al. Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin 2004;20:433-9
-
(2004)
Curr Med Res Opin
, vol.20
, pp. 433-439
-
-
Roux, C.1
Seeman, E.2
Eastell, R.3
-
18
-
-
0034530951
-
Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial
-
FIT Research Group
-
Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 2000;85:4118-24
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 4118-4124
-
-
Black, D.M.1
Thompson, D.E.2
Bauer, D.C.3
-
19
-
-
1642292806
-
Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy
-
Delmas PD, Seeman E. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 2004;34:599-604
-
(2004)
Bone
, vol.34
, pp. 599-604
-
-
Delmas, P.D.1
Seeman, E.2
-
20
-
-
0036963450
-
Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodelling in postmenopausal women with osteoporosis
-
Johnell O, Scheele WH, Lu Y, et al. Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodelling in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2002;87:985-92
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 985-992
-
-
Johnell, O.1
Scheele, W.H.2
Lu, Y.3
-
21
-
-
0036133366
-
Bone turnover matters: The raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density
-
Riggs BL, Melton LJ, III. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res 2002;17:11-4
-
(2002)
J Bone Miner Res
, vol.17
, pp. 11-14
-
-
Riggs, B.L.1
Melton III, L.J.2
-
22
-
-
0141527583
-
Is the paradigm shifting?
-
Heaney RP. Is the paradigm shifting? Bone 2003;33:457-65
-
(2003)
Bone
, vol.33
, pp. 457-465
-
-
Heaney, R.P.1
|